Old Web
English
Sign In
Acemap
>
Paper
>
Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.
Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.
2021
Pascual Cristina Contreras
Mendez Cristina Montalban
Tirado Antonio Moreno
Zhao Montero Benítez Maria
González Lázaro Paloma
Silva-Fernández Julia
Del Val Zaballos Florentino
Javier Gómez Alfonso Francisco
Meneses Amparo Lomas
Gómez García Inés
Keywords:
Internal medicine
Medullary thyroid cancer
alternative therapy
Oncology
Lenvatinib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]